 
FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations
The following statement is attributed to FDA Commissioner Robert M. Califf, M.D.
In February 2022, I rejoined the FDA as Commissioner of Food and Drugs, having served in the role five years earlier. Since my return, the agency has taken many significant actions that benefit the public health. Yet at the same time, the agency has confronted a series of challenges that have tested our regulatory frameworks and stressed the agency’s operations, prompting me to take a closer look at how we do business.
As a result, for two of the agency’s key programs, I have commissioned external agency experts to conduct a comprehensive evaluation for:
- The agency’s Human Foods Program, including the Office of Food Response and Policy, Center for Food Safety and Applied Nutrition, as well as relevant parts of the Office of Regulatory Affairs
- The Center for Tobacco Products
The Reagan-Udall Foundation, an independent partner organization for the agency, will be working with an external group of experts on the evaluation.
About Us
The Stakeholder Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, consumer groups, trade associations, patient advocacy organizations, think tanks/academia, and other stakeholders, in order to better inform our policy making process, identify policy hurdles or stakeholder misconceptions, and create strategic collaborations.
|
